OrbiMed’s Humana HUM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-109,900
| Closed | -$50.3M | – | 119 |
|
|
2023
Q4 | $50.3M | Sell |
109,900
-232,600
| -68% | -$115M | 1% | 36 |
|
|
2023
Q3 | $167M | Sell |
342,500
-6,200
| -2% | -$2.91M | 3.54% | 3 |
|
|
2023
Q2 | $156M | Hold |
348,700
| – | – | 2.83% | 7 |
|
|
2023
Q1 | $169M | Hold |
348,700
| – | – | 3.32% | 4 |
|
|
2022
Q4 | $179M | Hold |
348,700
| – | – | 3.42% | 5 |
|
|
2022
Q3 | $169K | Sell |
348,700
-17,000
| -5% | -$8.27M | 3.14% | 3 |
|
|
2022
Q2 | $171K | Sell |
365,700
-16,000
| -4% | -$7.12M | 3.1% | 3 |
|
|
2022
Q1 | $166M | Buy |
381,700
+63,400
| +20% | +$26.5M | 2.69% | 7 |
|
|
2021
Q4 | $148M | Sell |
318,300
-16,700
| -5% | -$7.39M | 1.9% | 11 |
|
|
2021
Q3 | $130M | Hold |
335,000
| – | – | 1.43% | 22 |
|
|
2021
Q2 | $148M | Buy |
335,000
+21,400
| +7% | +$9.35M | 1.5% | 19 |
|
|
2021
Q1 | $131M | Buy |
313,600
+27,500
| +10% | +$11M | 1.23% | 21 |
|
|
2020
Q4 | $117M | Buy |
286,100
+5,800
| +2% | +$2.41M | 1.03% | 28 |
|
|
2020
Q3 | $116M | Hold |
280,300
| – | – | 1.46% | 20 |
|
|
2020
Q2 | $109M | Hold |
280,300
| – | – | 1.53% | 21 |
|
|
2020
Q1 | $88M | Sell |
280,300
-111,600
| -28% | -$37.6M | 1.48% | 26 |
|
|
2019
Q4 | $144M | Buy |
391,900
+210,100
| +116% | +$66.6M | 2.05% | 15 |
|
|
2019
Q3 | $46.5M | Buy |
+181,800
| New | +$51M | 0.88% | 34 |
|
|
2019
Q2 | – | Sell |
-210,300
| Closed | -$55.9M | – | 133 |
|
|
2019
Q1 | $55.9M | Buy |
210,300
+3,800
| +2% | +$1.1M | 0.87% | 36 |
|
|
2018
Q4 | $59.2M | Sell |
206,500
-186,500
| -47% | -$59.1M | 1.09% | 28 |
|
|
2018
Q3 | $133M | Buy |
393,000
+320,400
| +441% | +$104M | 1.6% | 17 |
|
|
2018
Q2 | $21.6M | Buy |
+72,600
| New | +$21.3M | 0.26% | 86 |
|
|
2017
Q3 | – | Sell |
-770,900
| Closed | -$185M | – | 147 |
|
|
2017
Q2 | $185M | Buy |
770,900
+28,600
| +4% | +$6.48M | 1.94% | 17 |
|
|
2017
Q1 | $153M | Sell |
742,300
-94,100
| -11% | -$19.5M | 1.73% | 17 |
|
|
2016
Q4 | $171M | Buy |
836,400
+412,900
| +97% | +$78.7M | 2.17% | 12 |
|
|
2016
Q3 | $74.9M | Buy |
423,500
+83,800
| +25% | +$14.5M | 0.85% | 46 |
|
|
2016
Q2 | $61.1M | Hold |
339,700
| – | – | 0.64% | 46 |
|
|
2016
Q1 | $62.1M | Buy |
+339,700
| New | +$58.9M | 0.65% | 42 |
|
Other funds holding HUM
DSA
OrbiMed's HUM Position: Q1 2024 in Review
OrbiMed sold out of Humana (HUM) in Q1 2024, closing a stake of 109,900 shares — an estimated $50.3M sold.
OrbiMed first reported a position in HUM in Q1 2016 and held it in 28 quarters. The position peaked at $185M in Q2 2017. 1,030 funds tracked by Wall St. Rank hold HUM as of Q1 2024.
- OrbiMed reported no remaining Humana position as of Q1 2024 after selling out during the quarter.
- OrbiMed sold 109,900 Humana shares in Q1 2024, an estimated $50.3M.
- OrbiMed first reported a position in Humana in Q1 2016 and held it in 28 quarters.
- OrbiMed's Humana position peaked at $185M in Q2 2017.
- 1,030 funds tracked by Wall St. Rank held Humana as of Q1 2024.
Based on OrbiMed's 13F filing for Q1 2024, filed 15 May 2024.